Researchers at the University of Kentucky have found that, for much of the past two decades, Appalachian Kentuckians have been more likely to die from colorectal cancer compared to the rest of the state and country's population.
Jun 13, 2024
0
0
There is no significant association between exposure to immunosuppressive therapies and development of incident cancers among patients with inflammatory bowel disease (IBD) and a history of cancer, according to a study published ...
Jun 11, 2024
0
0
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in the digestive tract. Ulcerative colitis affects the innermost lining of the large intestine, also called the colon ...
Jun 3, 2024
0
0
Researchers at Edith Cowan University's (ECU's) Center for Precision Health have uncovered a significant genetic connection between type 2 diabetes and certain gut disorders, which could pave the way for more effective therapies. ...
May 30, 2024
0
28
In the fall of 2023, NIST's scientists in Charleston, South Carolina, received a special shipment of containers packed with baggies full of frozen human feces.
May 30, 2024
0
4
In a study published in Cell Host & Microbe, a research team has demonstrated the causal link between microbial factors and dysfunction of intestinal stem cells (ISCs) in colitis. On the basis of this mechanism, they proposed ...
May 24, 2024
0
0
Inflammatory bowel disease (IBD) is associated with a slightly increased risk of heart failure up to 20 years after diagnosis, according to a comprehensive registry study from Karolinska Institutet in Sweden published in ...
May 21, 2024
0
0
Many kids can get an occasional upset tummy, but what if your child's stomachaches are more persistent?
May 21, 2024
0
0
Researchers at the Icahn School of Medicine at Mount Sinai have made a significant discovery, identifying genetic connections between inflammatory bowel disease (IBD) and Parkinson's disease (PD). Published in Genome Medicine ...
May 14, 2024
0
50
A clinical trial led by Birmingham researchers investigated targeting a molecule causing liver inflammation and fibrosis to treat patients with Primary sclerosing cholangitis (PSC)—a debilitating liver disease for which ...
May 14, 2024
0
0
